ES2058992T3 - Un procedimiento para la preparacion de polipeptido que estimula celulas t. - Google Patents

Un procedimiento para la preparacion de polipeptido que estimula celulas t.

Info

Publication number
ES2058992T3
ES2058992T3 ES91110233T ES91110233T ES2058992T3 ES 2058992 T3 ES2058992 T3 ES 2058992T3 ES 91110233 T ES91110233 T ES 91110233T ES 91110233 T ES91110233 T ES 91110233T ES 2058992 T3 ES2058992 T3 ES 2058992T3
Authority
ES
Spain
Prior art keywords
polypeptide
stimulates
cells
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91110233T
Other languages
English (en)
Inventor
Carlo Ferrari
Giuseppe Colucci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clonit SpA
Original Assignee
Clonit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clonit SpA filed Critical Clonit SpA
Application granted granted Critical
Publication of ES2058992T3 publication Critical patent/ES2058992T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN POLIPEPTIDO ESTIMULADOR DE CELULA T CONSISTE ESENCIALMENTE EN UNA SECUENCIA DE AMINOACIDO DE FORMULA (I): PHHTALRQAILCWELMTLA. ESTE POLIPEPTIDO PUEDE UNIRSE OPERATIVAMENTE A UN INMUNOGEN POLIPEPTIDO COMO HBSAG.
ES91110233T 1990-07-31 1991-06-21 Un procedimiento para la preparacion de polipeptido que estimula celulas t. Expired - Lifetime ES2058992T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016727A GB9016727D0 (en) 1990-07-31 1990-07-31 Amino acid residue sequence of hepatitis b core antigen

Publications (1)

Publication Number Publication Date
ES2058992T3 true ES2058992T3 (es) 1994-11-01

Family

ID=10679903

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91110233T Expired - Lifetime ES2058992T3 (es) 1990-07-31 1991-06-21 Un procedimiento para la preparacion de polipeptido que estimula celulas t.

Country Status (9)

Country Link
EP (1) EP0469281B1 (es)
JP (1) JP3000569B2 (es)
KR (1) KR920002629A (es)
AT (1) ATE90689T1 (es)
CA (1) CA2048029A1 (es)
DE (1) DE69100129T2 (es)
DK (1) DK0469281T3 (es)
ES (1) ES2058992T3 (es)
GB (1) GB9016727D0 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780036A (en) * 1991-08-26 1998-07-14 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
CZ42894A3 (en) * 1991-08-26 1995-02-15 Scripps Research Inst Peptides inducing cytotoxic response of t lymphocytes to hepatitis b virus
US6607727B1 (en) 1991-08-26 2003-08-19 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
US6689363B1 (en) 1992-01-29 2004-02-10 Epimmune Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
US7611713B2 (en) 1993-03-05 2009-11-03 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide compositions
US6235288B1 (en) 1992-08-26 2001-05-22 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
JP4176820B2 (ja) * 1993-11-05 2008-11-05 明治乳業株式会社 スギ花粉アレルゲンＣｒｙｊＩＩエピトープ
JP3649460B2 (ja) * 1993-11-05 2005-05-18 明治乳業株式会社 スギ花粉アレルゲンＣｒｙ ｊ ＩＩエピトープ
DE19901009A1 (de) * 1999-01-13 2000-07-20 Deutsches Krebsforsch Peptide zur Inhibierung von HBV-Core-Proteinen
GB0006693D0 (en) * 2000-03-20 2000-05-10 Glaxo Group Ltd Vaccine
US20060057405A1 (en) * 2002-09-20 2006-03-16 Seiji Kagawa Method and apparatus for producing polybutylene terephthalate film, and shape-memory polybutylene terephthalate laminate film

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein

Also Published As

Publication number Publication date
KR920002629A (ko) 1992-02-28
EP0469281A1 (en) 1992-02-05
DE69100129T2 (de) 1993-09-23
DE69100129D1 (de) 1993-07-22
DK0469281T3 (da) 1994-01-03
JPH05213995A (ja) 1993-08-24
GB9016727D0 (en) 1990-09-12
EP0469281B1 (en) 1993-06-16
ATE90689T1 (de) 1993-07-15
JP3000569B2 (ja) 2000-01-17
CA2048029A1 (en) 1992-02-01

Similar Documents

Publication Publication Date Title
DK230188A (da) Grundlag for slimhinde- og proteseklaebepastaer samt fremstilling og anvendelse heraf
GR1000039B (el) Ενεργος ειδικη ανοσοαναστολη.
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
IT8683390A0 (it) Caricatore miscelatore per iniettori transcutanei.
AT400296B (de) Dosierungsform zur schnellen abgabe eines wirkstoffes gefolgt von einer langsamen abgabe eines wirkstoffes
ES2058992T3 (es) Un procedimiento para la preparacion de polipeptido que estimula celulas t.
DK520784D0 (da) Cycliske polypeptider, deres fremstilling og anvendelse
DK164088A (da) Syntetiske peptidantigener til paavisning af hiv-1-infektion
IT8021972A0 (it) Procedimento per la preparazione di n-fosfonometil glicina.
DE3789487D1 (de) Vorrichtung zur Erzeugung von Elektronenstrahlen.
NO884434D0 (no) Aminosyrederivater.
BG45552A3 (bg) Метод за получаване на 2-фенил-хексахидро-1,2,4- триазин-3,5-диони
DK412488A (da) Fremgangsmaade til fremstilling af guinoloncarboxylsyrer
ES2034953T3 (es) Un procedimiento para la preparacion de una tiazolona.
DK434788A (da) Fremgangsmaade til fremstilling af umaettede aminosyreforbindelser
IE810276L (en) Phenylpiperazine derivatives of oxadiazoles
DK516087A (da) Fremgangsmaade til flokkulering af en vandig oploesning
ES2019634B3 (es) Terapia con clorfeniramina.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
NO871912L (no) Fremgangsmaate for fremstilling av en animalsk celletransformant.
DE3870720D1 (de) Ionenquelle mit vier elektroden.
DE3888053D1 (de) Implantierbare Elektrode zur Herzstimulation.
NO885315L (no) Homogen vandig opploesning for elektrolyttpaavisning.
ATE95422T1 (de) Ein synthetisches nonapeptid zur verwendung als adjuvant.
IT8922146A0 (it) Procedimento per il trattamento di pile esauste

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 469281

Country of ref document: ES